- Home
- NCRA vs APM Comparison
NCRA vs APM Comparison
Compare NCRA & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- APM
- Stock Information
- Founded
- NCRA 2002
- APM 2010
- Country
- NCRA Taiwan
- APM United Kingdom
- Employees
- NCRA N/A
- APM N/A
- Industry
- NCRA Farming/Seeds/Milling
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- APM Health Care
- Exchange
- NCRA Nasdaq
- APM Nasdaq
- Market Cap
- NCRA 16.1M
- APM 18.9M
- IPO Year
- NCRA N/A
- APM 2018
- Fundamental
- Price
- NCRA $1.01
- APM $1.34
- Analyst Decision
- NCRA
- APM
- Analyst Count
- NCRA 0
- APM 0
- Target Price
- NCRA N/A
- APM N/A
- AVG Volume (30 Days)
- NCRA 1.9M
- APM 106.9K
- Earning Date
- NCRA 11-14-2025
- APM 12-19-2025
- Dividend Yield
- NCRA N/A
- APM N/A
- EPS Growth
- NCRA N/A
- APM N/A
- EPS
- NCRA N/A
- APM N/A
- Revenue
- NCRA $14,106,275.00
- APM N/A
- Revenue This Year
- NCRA N/A
- APM N/A
- Revenue Next Year
- NCRA N/A
- APM N/A
- P/E Ratio
- NCRA N/A
- APM N/A
- Revenue Growth
- NCRA N/A
- APM N/A
- 52 Week Low
- NCRA $0.70
- APM $0.59
- 52 Week High
- NCRA $2.40
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- NCRA 34.29
- APM 39.52
- Support Level
- NCRA $0.94
- APM $1.21
- Resistance Level
- NCRA $1.14
- APM $1.72
- Average True Range (ATR)
- NCRA 0.12
- APM 0.12
- MACD
- NCRA -0.02
- APM 0.01
- Stochastic Oscillator
- NCRA 17.74
- APM 17.65
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.